IGEM:Paris Bettencourt 2012: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Line 17: Line 17:
** [http://www.google.fr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CFYQFjAA&url=http%3A%2F%2Feur-lex.europa.eu%2FLexUriServ%2FLexUriServ.do%3Furi%3DOJ%3AL%3A2001%3A106%3A0001%3A0001%3AFR%3APDF&ei=p1T1T9DNKIic0AWcwpzABw&usg=AFQjCNE7TBZG-flrB5aw07XmlVPW2Me2Ig&sig2=qU14TvQSaQiYvzWPuZtdJA in french]
** [http://www.google.fr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&ved=0CFYQFjAA&url=http%3A%2F%2Feur-lex.europa.eu%2FLexUriServ%2FLexUriServ.do%3Furi%3DOJ%3AL%3A2001%3A106%3A0001%3A0001%3AFR%3APDF&ei=p1T1T9DNKIic0AWcwpzABw&usg=AFQjCNE7TBZG-flrB5aw07XmlVPW2Me2Ig&sig2=qU14TvQSaQiYvzWPuZtdJA in french]
** [http://www.google.fr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=3&ved=0CFwQFjAC&url=http%3A%2F%2Feur-lex.europa.eu%2FJOHtml.do%3Fyear%3D2001%26serie%3DL%26textfield2%3D106%26Submit%3DSearch&ei=p1T1T9DNKIic0AWcwpzABw&usg=AFQjCNGaSemphmrDZ-mGeVk7w_T0gBQ_Sg&sig2=wZHXpQLL1thmNFMM063rHg in english]
** [http://www.google.fr/url?sa=t&rct=j&q=&esrc=s&source=web&cd=3&ved=0CFwQFjAC&url=http%3A%2F%2Feur-lex.europa.eu%2FJOHtml.do%3Fyear%3D2001%26serie%3DL%26textfield2%3D106%26Submit%3DSearch&ei=p1T1T9DNKIic0AWcwpzABw&usg=AFQjCNGaSemphmrDZ-mGeVk7w_T0gBQ_Sg&sig2=wZHXpQLL1thmNFMM063rHg in english]
*Here they say that the previous directive will be apply to synthetic biology products : [https://docs.google.com/viewer?a=v&q=cache:FyFibtBsOGIJ:ec.europa.eu/bepa/european-group-ethics/docs/press_release_opinion_25_fr.pdf+&hl=fr&gl=fr&pid=bl&srcid=ADGEESgmDY7SsQkB1Zhd04g_43D5rvNjVjS9YXa0kVVFcyswX76nX-fsB9H14o2tU2MYvMBpewQUinNiGVaw7axA3fgorXW-8Yj2GO38ZspNSYaPEOLv8RjtDGNjfHF4L1pWcO9L_pGw&sig=AHIEtbQ0eeQC4opG625ANyV7ItwEFz7L9A Press release, French] (lenght : -)
*Here they say that the previous directive will be apply to synthetic biology products : [https://docs.google.com/viewer?a=v&q=cache:FyFibtBsOGIJ:ec.europa.eu/bepa/european-group-ethics/docs/press_release_opinion_25_fr.pdf+&hl=fr&gl=fr&pid=bl&srcid=ADGEESgmDY7SsQkB1Zhd04g_43D5rvNjVjS9YXa0kVVFcyswX76nX-fsB9H14o2tU2MYvMBpewQUinNiGVaw7axA3fgorXW-8Yj2GO38ZspNSYaPEOLv8RjtDGNjfHF4L1pWcO9L_pGw&sig=AHIEtbQ0eeQC4opG625ANyV7ItwEFz7L9A Press release, French] (lenght : - )
* Les enjeux de la biologie de synthèse : [http://www.senat.fr/rap/r11-378-1/r11-378-1.html in french] (lenght : ++++ don't read everything, of course)
* Les enjeux de la biologie de synthèse : [http://www.senat.fr/rap/r11-378-1/r11-378-1.html in french] (lenght : ++++ don't read everything, of course)
**[http://www.senat.fr/rap/r11-378-1/r11-378-119.html#toc95 L'IMPACT DE LA BIOLOGIE DE SYNTHÈSE SUR LES RÉGULATIONS ET LES ENJEUX SOCIÉTAUX] : this part is very interesting, I will summarize it soon. There are references to english paper at the bottom of the page.


===Summarize this document in english===
===Summarize this document in english===

Revision as of 02:31, 5 July 2012

Welcome to iGEM Paris Bettencourt 2012 Wiki

This page need to be designed. This is a place holder. Here are the sections we plan to use:

Notebooks Design Roadmap Meetings and to-dos Protocols Bibliography Previous Biosafety iGEM projects

We need to do :

Read some legislative and ethic report

Summarize this document in english